Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01D
- Chemical subgroupJ01DC
- Chemical substanceJ01DC05Cefotetan
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 4 registrations
- Cefotetan10GM BASE/VIAL, 1GM BASE/VIAL, 2GM BASE/VIAL · injectable · Hikma
- Cefotan10GM BASE/VIAL, 1GM BASE/VIAL, 2GM BASE/VIAL · injectable · Teligent
- Cefotan in Plastic Container20MG BASE/ML, 40MG BASE/ML · injectable · Pai Holdings Pharm
- Cefotetan and Dextrose in Duplex Container1GM BASE/VIAL, 2GM BASE/VIAL · injectable · B Braun
Canada
Health Canada · 3 registrations
At a glance
- ATC code
- J01DC05
- ATC group
- Anti-infectives for systemic use
- Registers
- 2
- Registrations
- 7
- With their own page
- 4
- Companies
- 6
All medicines with Cefotetan
Human medicines from every register that match Cefotetan by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
7 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cefotetan | United States | 10GM BASE/VIAL, 1GM BASE/VIAL, 2GM BASE/VIAL | injectable | Marketed | Hikma |
| Cefotan | United States | 10GM BASE/VIAL, 1GM BASE/VIAL, 2GM BASE/VIAL | injectable | Marketed | Teligent |
| Cefotetan and Dextrose in Duplex Container | United States | 1GM BASE/VIAL, 2GM BASE/VIAL | injectable | Not marketed | B Braun |
| Cefotan in Plastic Container | United States | 20MG BASE/ML, 40MG BASE/ML | injectable | Not marketed | Pai Holdings Pharm |
| Cefotan Inj 2GM/Vial | Canada | 2 G / VIAL | Powder For Solution | Cancelled | Ayerst Laboratories |
| Cefotan Injection - 1G | Canada | 1 G / VIAL | Powder For Solution | Cancelled | Wyeth Canada |
| Cefotan Injection - 2 G | Canada | 2 G / VIAL | Powder For Solution | Cancelled | Wyeth Canada |